Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2004 May 14;1(1):5.
doi: 10.1186/1742-2094-1-5.

PPARgamma, Neuroinflammation, and Disease

Affiliations
Free PMC article
Editorial

PPARgamma, Neuroinflammation, and Disease

Robert E Mrak et al. J Neuroinflammation. .
Free PMC article

Abstract

BACKGROUND: Peroxisome proliferator-activated receptors (PPARs) are a class of nuclear transcription factors that are activated by fatty acids and their derivatives. One of these, PPARgamma, regulates responsiveness to insulin in adipose cells, and PPARgamma-activating drugs such as pioglitazone are used in the treatment of type 2 diabetes. PPARgamma acts in myeloid-lineage cells, including T-cells and macrophages, to suppress their activation and their elaboration of inflammatory molecules. PPARgamma activation also suppresses the activated phenotype in microglia, suggesting that PPARgamma-activating drugs may be of benefit in chronic neuroinflammatory diseases. Some, but not all, nonsteroidal anti-inflammatory agents (indomethacin and ibuprofen in particular) also have activating effects on PPARgamma. DISCUSSION AND CONCLUSIONS: These observations suggest on the one hand a role for PPARgamma-activating drugs in the treatment of chronic neuroinflammatory diseases-as shown for a patient with secondary progressive multiple sclerosis by Pershadsingh et al. in this issue of the Journal of Neuroinflammation-and suggest on the other hand a possible explanation for confusing and contradictory results in trials of nonsteroidal anti-inflammatory agents in Alzheimer's disease.

Similar articles

See all similar articles

Cited by 16 articles

See all "Cited by" articles

References

    1. Pershadsingh HA, Heneka MT, Saini R, Amin NM, Broeske DJ, Feinstein DL. Effect of pioglitazone treatment in a patient with secondary multiple sclerosis. J Neuroinflamm. 2004;1:3. doi: 10.1186/1742-2094-1-3. - DOI - PMC - PubMed
    1. Rhodin J. Further studies on the nephron ultrastructure in mouse. Terminal part of proximal convolution. In: Sjostrand FS, Rhodin J, editor. Electron Microscopy: Proceedings of the Stockholm Conference. New York: Academic Press; 1957.
    1. De Duve C, Baudhuin P. Peroxisomes (microbodies and related particles) Physiol Rev. 1966;46:323–357. - PubMed
    1. Lake BG. Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. Annu Rev Pharmacol Toxicol. 1995;35:483–507. doi: 10.1146/annurev.pa.35.040195.002411. - DOI - PubMed
    1. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990;347:645–650. doi: 10.1038/347645a0. - DOI - PubMed

Publication types

LinkOut - more resources

Feedback